Ranitidine recall in Canada: May increase cancer risk
In plain language
This recall involves ranitidine drugs, including those sold under the brand name Zantac, in Canada. They are being recalled because they may contain an impurity called NDMA, which could increase the risk of cancer with long-term exposure. Health Canada is assessing the issue and will take action as needed.
What to do
- Speak to your doctor or pharmacist if you are taking ranitidine and have concerns.
- Do not stop taking prescription ranitidine without first consulting your healthcare provider.
- Consider alternative treatment options by speaking with your doctor or pharmacist.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Why this matters
May increase cancer risk
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
May increase cancer risk
What should consumers do?
Speak to your doctor or pharmacist if you are taking ranitidine and have concerns. Do not stop taking prescription ranitidine without first consulting your healthcare provider. Consider alternative treatment options by speaking with your doctor or pharmacist.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. May increase cancer risk
When was this product recalled?
This product was recalled on September 13, 2019.
Is the Zantac brand affected by this recall?
Yes, Zantac products are affected by this recall. This recall involves ranitidine drugs, including those sold under the brand name Zantac, in Canada. They are being recalled because they may contain an impurity called NDMA, which could increase the risk of cancer with long-term exposure. Health Canada is assessing the issue and will take action as needed.